Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Wollemia nobilis
An extraordinarily rare Australian conifer discovered in 1994; limited folk medicinal use in conservation context.
Wollemia nobilis, the Wollemi pine, is a critically endangered Australian conifer discovered in 1994, with no established medicinal use and limited research. Its active compounds include biflavones, terpenes, and flavonoids, which suggest potential antioxidant and anti-inflammatory properties, but human data are absent. The species is protected, and any collection is prohibited, making it relevant only for conservation and ornamental purposes.
Preliminary in vitro studies indicate that biflavones from Wollemia nobilis may inhibit cyclooxygenase-2 (COX-2) and lipoxygenase pathways, reducing pro-inflammatory prostaglandin and leukotriene synthesis. Terpenes such as α-pinene and limonene could modulate GABA-A receptors, but no receptor-specific data exist for this species. Flavonoids may act as free radical scavengers, but their bioavailability and clinical relevance remain unstudied. No human pharmacokinetic or pharmacodynamic data are available.
An extraordinarily rare Australian conifer discovered in 1994; limited folk medicinal use in conservation context.
Wollemia nobilis, the Wollemi pine, is a critically endangered Australian conifer discovered in 1994, with no established medicinal use and limited research. Its active compounds include biflavones, terpenes, and flavonoids, which suggest potential antioxidant and anti-inflammatory properties, but human data are absent. The species is protected, and any collection is prohibited, making it relevant only for conservation and ornamental purposes.
Preliminary in vitro studies indicate that biflavones from Wollemia nobilis may inhibit cyclooxygenase-2 (COX-2) and lipoxygenase pathways, reducing pro-inflammatory prostaglandin and leukotriene synthesis. Terpenes such as α-pinene and limonene could modulate GABA-A receptors, but no receptor-specific data exist for this species. Flavonoids may act as free radical scavengers, but their bioavailability and clinical relevance remain unstudied. No human pharmacokinetic or pharmacodynamic data are available.